欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号AT/H/0343/002
药品名称Feiba 1000 E. Pulver und Lösungsmittel zur Herstellung einer Injektionslösung
活性成分
    • FACTOR VIII INHIBITOR BYPASSING FRACTION 50.0 E
剂型Powder and solvent for solution for injection
上市许可持有人Baxter AG Industriestrasse 67 A-1221 Vienna
参考成员国 - 产品名称Austria (AT)
FEIBA 1000 E. Pulver und Lösungsmittel zur Herstellung einer Infusionslösung
互认成员国 - 产品名称
    • Malta (MT)
      FEIBA 50 U/ml powder and solvent for solution for infusion
    • Ireland (IE)
    • Greece (GR)
    • Norway (NO)
    • Slovenia (SI)
    • Slovakia (SK)
    • Germany (DE)
    • Netherlands (NL)
      Feiba 50E/ml
    • Czechia (CZ)
      Feiba NF 50 U/ml prášek a rozpouštědlo pro injekční/infuzní roztok
    • Denmark (DK)
    • Spain (ES)
    • Sweden (SE)
    • Bulgaria (BG)
    • Croatia (HR)
    • Cyprus (CY)
    • Estonia (EE)
      FEIBA 50 Ü/ML
    • Finland (FI)
    • Romania (RO)
      FEIBA 50 U/ml pulbere şi solvent pentru soluţie perfuzabilă
    • Lithuania (LT)
    • Latvia (LV)
许可日期2009/12/11
最近更新日期2023/11/09
药物ATC编码
    • B02BD03 factor VIII inhibitor bypassing activity
申请类型
  • TypeLevel1：Known Active Substance
  • TypeLevel2：Additional Strength/Form
  • TypeLevel3：Full Dossier Art 8.3(i) Dir 2001/83/EC
  • TypeLevel4：Biological: Blood Product
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase